Overview
Omar Nadeem is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Nadeem is rated as a Distinguished provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Nadeem is currently accepting new patients.
His clinical research consists of co-authoring 76 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Relapsed Refractory Multiple Myeloma (RRMM).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
7 Clinical Trials
Dana-Farber Cancer Institute, Inc.
Jacob Laubach is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Laubach is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Laubach is currently accepting new patients.
Massachusetts General Physicians Organization Inc
Noopur Raje is a Hematologist and an Oncologist in Boston, Massachusetts. Dr. Raje is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). Her top areas of expertise are Multiple Myeloma, Plasmacytoma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Vertebroplasty. Dr. Raje is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Paul Richardson is a Hematologist Oncology specialist and an Oncologist in Milford, Massachusetts. Dr. Richardson is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). His top areas of expertise are Multiple Myeloma, Hepatic Venoocclusive Disease with Immunodeficiency, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Graft. Dr. Richardson is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Multiple MyelomaDr. Nadeem isElite. Learn about Multiple Myeloma.
- Smoldering Multiple MyelomaDr. Nadeem isElite. Learn about Smoldering Multiple Myeloma.
- Distinguished
- Adult Immune ThrombocytopeniaDr. Nadeem isDistinguished. Learn about Adult Immune Thrombocytopenia.
- Chronic Lymphocytic Leukemia (CLL)Dr. Nadeem isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Hemangioma Thrombocytopenia SyndromeDr. Nadeem isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- Myelodysplastic Syndrome (MDS)Dr. Nadeem isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaDr. Nadeem isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Relapsed Refractory Multiple Myeloma (RRMM)Dr. Nadeem isDistinguished. Learn about Relapsed Refractory Multiple Myeloma (RRMM).
- Advanced
- AgranulocytosisDr. Nadeem isAdvanced. Learn about Agranulocytosis.
- AnemiaDr. Nadeem isAdvanced. Learn about Anemia.
- Chronic B-Cell Leukemia (CBCL)Dr. Nadeem isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Essential ThrombocythemiaDr. Nadeem isAdvanced. Learn about Essential Thrombocythemia.
- Familial Colorectal CancerDr. Nadeem isAdvanced. Learn about Familial Colorectal Cancer.
- Follicular LymphomaDr. Nadeem isAdvanced. Learn about Follicular Lymphoma.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Nadeem isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Arterial EmbolismDr. Nadeem isExperienced. Learn about Arterial Embolism.
- B-Cell LymphomaDr. Nadeem isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow AspirationDr. Nadeem isExperienced. Learn about Bone Marrow Aspiration.